Navigation Links
Cardica Announces Publication of Case Report in the Journal of Neurosurgery Featuring Use of C-Port(R) System in Brain Arterial Bypass
Date:11/10/2008

- Dr. Ralph G. Dacey, Jr., Successfully Uses C-Port System to Bypass

Cerebral Aneurysm in Patient with Brain Injury -

REDWOOD CITY, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced publication of a case study in the September issue of the peer-reviewed Journal of Neurosurgery featuring the use of Cardica's C-Port xA(R) Distal Anastomosis System to connect blood vessels in the brain to bypass an enlarging aneurysm.

Ralph G. Dacey, Jr., M.D., professor and chairman of neurological surgery at Washington University School of Medicine in St. Louis, and his colleagues performed neurosurgery on a 43-year-old male patient who sustained a subarachnoid hemorrhage after being assaulted and, as a result, experienced an enlarging aneurysm. Using the C-Port system, the neurosurgeons bypassed the aneurysm using a saphenous vein graft extending from the extracranial common carotid artery to the intracranial middle cerebral artery. The C-Port system performed an automated anastomosis by inserting 13 tiny staples into the graft and recipient vessel. The bypass was demonstrated to be patent (open) on intraoperative and postoperative arteriography, and the patient subsequently made a good neurologic recovery.

"By using the C-Port system instead of hand sewing the vessels in the brain, we were able to reliably connect the graft vessel and significantly reduce the length of time that blood flow was cut off from the brain in this patient," said Dr. Dacey. "In appropriate patients, we believe the C-Port system is a useful addition to the arsenal of tools that neurovascular surgeons have to surgically bypass cerebral aneurysms. We are looking forward to using it in other suitable cases."

The Journal of Neurosurgery September issue also included results from a preclinical feasibility study of the use of the C-Port xA system to connect blood vessels in neurological bypass procedures. The study, conducted by surgeons at the University of Bern, Washington University and Heinrich-Heine- Universitat in Dusseldorf, demonstrated that the C-Port xA could reliably and consistently perform an anastomosis for an extracranial-intracranial high-flow bypass to the middle cerebral artery.

"Publication of the first use of the C-Port xA system in a successful arterial bypass in a patient with an intracranial aneurysm, together with the results of the neurologic preclinical feasibility study, demonstrate the versatility and diverse functionality of Cardica's C-Port systems in connecting blood vessels," said Bernard A. Hausen, M.D., Ph.D., president and chief executive officer of Cardica. "We are exploring additional applications for our automated anastomosis systems in cerebrovascular neurosurgery and other fields beyond cardiothoracic surgery."

About Cardica

Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in the United States and Europe and its PAS-Port(R) Proximal Anastomosis System is marketed in the United States, Europe and Japan. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures.

Forward-Looking Statements

This press release contains "forward-looking" statements, including statements relating to the potential expansion of uses for and increased adoption of the C-Port systems, specifically, and of automated anastomosis devices generally, for CABG and neurological procedures. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words "exploring," "looking," "believe" or similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including risks associated with the need for Cardica's products to gain market acceptance, and the long-term patency rates of grafts connected using Cardica's products, as well as other risks detailed from time to time in Cardica's SEC reports, including its Annual Report on Form 10-Q for the fiscal year ended September 30, 2008. Cardica does not undertake any obligation to update forward-looking statements. You are encouraged to read the Cardica's reports filed with the U.S. Securities and Exchange Commission, available at http://www.sec.gov.


'/>"/>
SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cardica to Present at William Blair Small-Cap Growth Stock Conference
2. Cardica to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Provide Positive Update on Pas-Port(R)
3. Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday, August 5, 2008
4. Cardica Names Frederick Bauer Vice President of Operations
5. Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons
6. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
7. Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008
8. Cardicas C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study
9. Cardicas C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University
10. Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday, January 24, 2008
11. Cardica Announces Exercise of Over-Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
(Date:4/24/2017)... ... April 24, 2017 , ... According to ... deaths now claim the lives of 62 Americans each day.(1) Yet since 2011, ... manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical Detox ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, ... HIV because it is not known to have significant interactions with antiretroviral therapy ... both lower cholesterol levels and dampen inflammation in the bloodstream. , While lowering ...
(Date:4/24/2017)... FOREST KNOLLS, Calif. (PRWEB) , ... April 24, 2017 , ... ... and health topics, but she has not found any of them to be very ... weekly actions to slowly and easily make changes in their health. It prompted her ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... , April 21, 2017 Halo Labs ... throughput biopharmaceutical particle analysis system called the Horizon at ... May 1st. The new system analyzes sub visible particulate ... time rapid particle screening as early as candidate selection ... with leading biopharma contract research organization Elion Labs ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
Breaking Medicine Technology: